Skip to main content
ADVANCED MEDICAL SOLUTIONS GROUP PLC logo

ADVANCED MEDICAL SOLUTIONS GROUP PLC — Investor Relations & Filings

Ticker · AMS ISIN · GB0004536594 LEI · 213800HJP6OWOSZI1L74 IL Manufacturing
Filings indexed 488 across all filing types
Latest filing 2024-11-01 Declaration of Voting R…
Country GB United Kingdom
Listing IL AMS

About ADVANCED MEDICAL SOLUTIONS GROUP PLC

https://admedsol.com/

Advanced Medical Solutions Group plc is a world-leading independent developer and manufacturer of innovative tissue-healing technologies. The company operates through two primary divisions: Surgical and Woundcare. The Surgical portfolio includes a range of products such as tissue adhesives, sutures, haemostats, and internal fixation devices designed for tissue closure and sealing. The Woundcare division focuses on advanced products for managing acute and chronic wounds, utilizing high-performance natural and synthetic polymers. The company is dedicated to delivering high-quality, innovative solutions that improve patient outcomes and provide value to clinicians and healthcare payors.

Recent filings

Filing Released Lang Actions
Total Voting Rights
Declaration of Voting Results & Voting Rights Announcements Classification · 100% confidence The document is identified by the header 'RNS Number : 6280K' and contains standard boilerplate language from RNS, the news service of the London Stock Exchange. The content explicitly states the 'Total Voting Rights' as of a specific date (31 October 2024) and provides the total number of ordinary shares (217,784,144). This type of mandatory disclosure regarding the total number of shares for voting purposes is a standard regulatory announcement. Since it is a short, specific regulatory update provided via RNS, and it doesn't fit into the more specific categories like Director's Dealing (DIRS), Major Shareholding Notification (MRQ), or Dividend Notice (DIV), the most appropriate classification is the general regulatory announcement category, RNS.
2024-11-01 English
Holding(s) in Company
Major Shareholding Notification Classification · 99% confidence The document is explicitly labeled with "RNS Number : 8321I" and contains the standard header/footer information associated with RNS (Regulatory News Service) announcements from the London Stock Exchange. The content details a "TR-1: Standard form for notification of major holdings" due to an acquisition or disposal of voting rights by Octopus Investments Limited, crossing a threshold. This type of filing, reporting changes in significant share ownership, directly corresponds to the Major Shareholding Notification category (MRQ). Although it is an RNS filing, MRQ is the more specific and appropriate classification over the general RNS fallback.
2024-10-18 English
Director/PDMR Shareholding
Director's Dealing Classification · 100% confidence The document is an official notification released via RNS (the news service of the London Stock Exchange). The title explicitly states 'Director/PDMR Shareholding'. It details a transaction (purchase) made by a Non-Executive Director (Grahame Cook) and includes the required regulatory disclosure format under the EU Market Abuse Regulation. This specific type of insider transaction reporting aligns perfectly with the definition of Director's Dealing.
2024-10-11 English
Total Voting Rights
Declaration of Voting Results & Voting Rights Announcements Classification · 100% confidence The document is very short (4273 characters) and its primary purpose is to announce a specific piece of regulatory information: the 'Total Voting Rights' as of a specific date (30 September 2024), referencing Disclosure and Transparency Rule 5.6.1. This type of mandatory disclosure, often issued via the RNS system of the London Stock Exchange, is a routine regulatory update. While it contains company information, it is not a full financial report (10-K, IR), an earnings release (ER), or a management discussion (MDA). It is a specific regulatory notification. Since it is a formal, required disclosure that doesn't fit the more specific categories like DIRS, DIV, or DVA, it falls best under the general 'Regulatory Filings' category (RNS) as a routine compliance update, or potentially DVA if it were voting results, but here it is about the denominator for voting calculations. Given the context of RNS Number and the nature of the disclosure, RNS is the most appropriate general regulatory filing code.
2024-09-30 English
Interim Results
Interim / Quarterly Report Classification · 100% confidence The document is an official announcement of 'Interim results for the six months ended 30 June 2024' for Advanced Medical Solutions Group plc. It contains detailed financial highlights, business performance analysis, and management commentary. It is a comprehensive financial report for a period shorter than a full fiscal year, fitting the definition of an Interim/Quarterly Report (IR). H1 2024
2024-09-18 English
Total Voting Rights
Declaration of Voting Results & Voting Rights Announcements Classification · 100% confidence The document is a formal announcement disseminated via RNS (Regulatory News Service), indicated by the 'RNS Number' header and the concluding boilerplate text referencing RNS and the London Stock Exchange. The core content explicitly states the 'Total Voting Rights' as of a specific date (30 August 2024) and provides the total number of issued ordinary shares (217,679,768). This type of notification, detailing the denominator for shareholder interest calculations under Disclosure and Transparency Rules, is a standard regulatory disclosure. While it relates to share capital, it is not a transaction (POS) or a general capital change announcement (SHA), but rather a mandatory periodic disclosure of the current share structure for transparency purposes. Since it is a specific regulatory update that doesn't fit perfectly into the other defined categories (like 10-K, ER, or DIV), and it is clearly a regulatory filing disseminated through the official channel, the most appropriate classification is the general regulatory filing category, RNS, as it is a standard disclosure required by the FCA.
2024-08-30 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.